Last updated on: 12/29/2008 | Author: ProCon.org

Paul C. Hébert, MD Biography

Title:
Editor-in-Chief of the Canadian Medical Association Journal (CMAJ)
Position:
Con to the question "Should Performance Enhancing Drugs (Such as Steroids) Be Accepted in Sports?"
Reasoning:

“Athletes are now competing on an Olympic stage. Some performances may be suspect and proven to be illegitimate. But the overwhelming majority of athletes will compete fairly and cleanly. Sadly, their accomplishments are sometimes overshadowed by the debased conduct of a minority. Athletes from Canada and from other countries are the product of sport systems that work tirelessly to address the doping scourge.

Antidoping programs in an Olympic setting ensure fair play and maintain public trust. A concern for drug use in community sport is equally important; the implications of such behavior compel thoughtful, strategic interventions to ensure sporting integrity and public health.”

“Doping, Sport and the Community,” Canadian Medical Association Journal (CMAJ), Aug. 12, 2008

Theoretical Expertise Ranking:
    Experts
Individuals with MDs, JDs, PhDs, or equivalent advanced degrees in fields relevant to performance enhancing drugs and sports. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to performance enhancing drugs and sports.
Involvement and Affiliations:
  • Editor-in-Chief, Canadian Medical Association Journal (CMAJ), Jan. 2, 2007-present
  • Professor of Medicine, Surgery, Anesthesiology and Epidemiology, in the Department of Medicine (Critical Care), Department of Anesthesiology and Surgery, and Department of Epidemiology & Community Medicine, University of Ottawa
  • Senior Scientist, Clinical Epidemiology, Ottawa Health Research Institute (OHRI)
  • Critical Care Physician, Ottawa Hospital
  • Chair, Transfusion and Critical Research, Ottawa Health Research Institute, University of Ottawa
  • Vice-Chair of Research, Department of Medicine at the University of Ottawa, 2003-2007
  • Recipient, Premier’s Research Excellence Award, Ontario Ministry of Health and Long-Term Care, 2002
  • Recipient, Researcher of the Year Award, OHRI, 2001
  • Established the University of Ottawa Centre for Transfusion Research, 1999
  • Established the Clinical Epidemiology Program at the General Campus of the Ottawa Hospital, 1998
  • Fellow, Royal College of Physicians and Surgeons of Canada (FRCPC)
Education:
  • MD, University of Ottawa, 1986
  • MHSc (Master of Health Sciences), Epidemiology, University of British Columbia, 1993
Other:
  • Primary area of research expertise is transfusion therapy, for which he has been published in the New England Journal of Medicine and the Journal of the American Medical Association
Quoted in:
  1. Is There Widespread Systemic Use of Banned Performance-Enhancing Drugs by Olympic Athletes?